RE: The NASDAQ effect22 Mar 2021 16:35
Hi
In terms of valuations, one BTC miner is more easily similar to another in a way drug companies simply arent. 4D is cheap as compared to other NASDAQ biotech - Seres being the most often quoted. However these are really complex businesses to value - comparative R&D, personnel, Patents - how far down regs and clinical studies their drugs are, how long cash will last and do they need to raise? etc - v hard to compare.
Here in miners - fairly easy to do some compares - qty mining capacity, hodl size, relative mining efficiency and profitability all clearer for the core business.
I became an Argonaut in November and I am still happy to be here - I feel that the moves we have made since then make Argo more attractive to me as a S/h than others miners - I would like price to rise but pretty sure it will follow in its own time.
GLA
NtD